Co-Authors
This is a "connection" page, showing publications co-authored by Jianxun Qi and Hao Song.
Connection Strength
0.396
-
Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design. EMBO J. 2020 10 15; 39(20):e105938.
Score: 0.226
-
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir. Signal Transduct Target Ther. 2021 02 04; 6(1):51.
Score: 0.058
-
Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2. Cell Discov. 2020; 6:68.
Score: 0.057
-
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat Commun. 2020 09 04; 11(1):4417.
Score: 0.056